210 related articles for article (PubMed ID: 38175716)
21.
Shangguan C; Yang C; Shi Z; Miao Y; Hai W; Shen Y; Qu Q; Li B; Mi J
Int J Radiat Oncol Biol Phys; 2024 Jan; 118(1):285-294. PubMed ID: 37634891
[TBL] [Abstract][Full Text] [Related]
22. 68Ga-FAPI PET/CT Detected Non-FDG-Avid Gastric Stromal Tumor.
Qiu L; Lan L; Liu H; Deng J; Chen Y
Clin Nucl Med; 2022 Mar; 47(3):226-227. PubMed ID: 34392281
[TBL] [Abstract][Full Text] [Related]
23. Comparison of [
Kömek H; Can C; Kaplan İ; Gündoğan C; Kepenek F; Karaoglan H; Demirkıran A; Ebinç S; Güzel Y; Gündeş E
Eur J Nucl Med Mol Imaging; 2022 Sep; 49(11):3898-3909. PubMed ID: 35578038
[TBL] [Abstract][Full Text] [Related]
24. Comparison of 68Ga-DOTA-FAPI-04 and 18F-FDG PET/CT in Patients With SAPHO Syndrome.
Wang P; Li C; Hou G; Li Z; Jing H; Zhang W; Li F
Clin Nucl Med; 2023 Sep; 48(9):781-784. PubMed ID: 37543757
[TBL] [Abstract][Full Text] [Related]
25. Gallium68-Labeled Fibroblast Activation Protein Inhibitor (68Ga-FAPI) PET/CT as an Alternative to Fluoro18-Fluorodeoxyglucose (18F-FDG) PET/CT: Discussion in a Case of Metastatic Adenocarcinoma of Pancreas.
Kumar A; Kumar B; Kumar Upadhyay A; Muthu GS; Mitra S
Cureus; 2023 Dec; 15(12):e50183. PubMed ID: 38186547
[TBL] [Abstract][Full Text] [Related]
26. [
Yang L; Xu S; Cheng L; Gao C; Cao S; Chang Z; Wang K
Eur J Nucl Med Mol Imaging; 2023 Nov; 50(13):4051-4063. PubMed ID: 37542659
[TBL] [Abstract][Full Text] [Related]
27. Comparison of 18F-FDG, 68Ga-FAPI, and 68Ga-DOTATATE PET/CT in a Patient With Pancreatic Neuroendocrine Tumor.
Cheng Z; Zou S; Cheng S; Song S; Zhu X
Clin Nucl Med; 2021 Sep; 46(9):764-765. PubMed ID: 34132674
[TBL] [Abstract][Full Text] [Related]
28. 68Ga-FAPI Versus 18F-FDG PET/CT in Evaluating Newly Diagnosed Breast Cancer Patients: A Head-to-Head Comparative Study.
Zheng S; Lin J; Zhu Y; Chen Y; Zhang J; Chen X; Miao W
Clin Nucl Med; 2023 Mar; 48(3):e104-e109. PubMed ID: 36723892
[TBL] [Abstract][Full Text] [Related]
29. Head-to-Head Comparison of [
Ballal S; Yadav MP; Roesch F; Raju S; Satapathy S; Sheokand P; Moon ES; Martin M; Awarwal S; Tripathi M; Bal C
Thyroid; 2023 Aug; 33(8):974-982. PubMed ID: 37171126
[No Abstract] [Full Text] [Related]
30. A Head-to-Head Comparison of 68Ga-LNC1007 and 2-18F-FDG/68Ga-FAPI-02 PET/CT in Patients With Various Cancers.
Zang J; Lin R; Wen X; Wang C; Zhao T; Jakobsson V; Yang Y; Wu X; Guo Z; Chen X; Zhang J; Miao W
Clin Nucl Med; 2023 Oct; 48(10):861-868. PubMed ID: 37682601
[TBL] [Abstract][Full Text] [Related]
31. FAPI Compared with FDG PET/CT for Diagnosis of Primary and Metastatic Lung Cancer.
Wei Y; Ma L; Li P; Lu J; Ren J; Yan S; Wu H; Yuan S; Fu Z; Yu J
Radiology; 2023 Aug; 308(2):e222785. PubMed ID: 37552075
[TBL] [Abstract][Full Text] [Related]
32. Head-to-head comparison of [
Ballal S; Yadav MP; Roesch F; Satapathy S; Moon ES; Martin M; Wakade N; Sheokand P; Tripathi M; Chandekar KR; Agarwal S; Sahoo RK; Rastogi S; Bal C
Eur J Nucl Med Mol Imaging; 2023 Dec; 51(1):233-244. PubMed ID: 37642703
[TBL] [Abstract][Full Text] [Related]
33. Comparison of 18F-FDG PET/CT and 68Ga-FAPI-04 PET/CT in the staging and restaging of gastric adenocarcinoma.
Gündoğan C; Kömek H; Can C; Yildirim ÖA; Kaplan İ; Erdur E; Poyraz K; Güzel Y; Oruç Z; Çakabay B
Nucl Med Commun; 2022 Jan; 43(1):64-72. PubMed ID: 34661379
[TBL] [Abstract][Full Text] [Related]
34. Positron emission tomography and computed tomography with [
Pang Y; Zhao L; Shang Q; Meng T; Zhao L; Feng L; Wang S; Guo P; Wu X; Lin Q; Wu H; Huang W; Sun L; Chen H
Eur J Nucl Med Mol Imaging; 2022 Mar; 49(4):1322-1337. PubMed ID: 34651226
[TBL] [Abstract][Full Text] [Related]
35. Comparison of [68Ga]-FAPI PET/CT and [18F]-FDG PET/CT in Multiple Myeloma: Clinical Experience.
Elboga U; Sahin E; Cayirli YB; Okuyan M; Aktas G; Haydaroglu Sahin H; Dogan I; Kus T; Akkurd DM; Cimen U; Mumcu V; Kilbas B; Celen YZ
Tomography; 2022 Feb; 8(1):293-302. PubMed ID: 35202189
[TBL] [Abstract][Full Text] [Related]
36. Superiority of 68Ga-FAPI-04 in Delineation of Soft Tissue and Liver Metastases in Chromophobe Renal Cell Carcinoma for Restaging.
Xie F; Fu L; Zhou W
Clin Nucl Med; 2022 Dec; 47(12):e758-e759. PubMed ID: 36342807
[TBL] [Abstract][Full Text] [Related]
37. Dual targeting PET tracer [
Wang R; Jakobsson V; Wang J; Zhao T; Peng X; Li B; Xue J; Liang N; Zhu Z; Chen X; Zhang J
Theranostics; 2023; 13(9):2979-2992. PubMed ID: 37284441
[No Abstract] [Full Text] [Related]
38. 18F-FDG PET/CT and 68Ga-FAPI-4 PET/CT Findings of Bilateral Knee Osteoarthritis in a Patient With Uveal Malignant Melanoma.
Erol Fenercioğlu Ö; Beyhan E; Ergül N; Arslan E; Çermik TF
Clin Nucl Med; 2022 Feb; 47(2):e144-e146. PubMed ID: 34319962
[TBL] [Abstract][Full Text] [Related]
39. [
Wei Y; Zheng J; Ma L; Liu X; Xu S; Wang S; Pei J; Cheng K; Yuan S; Yu J
Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2761-2773. PubMed ID: 35262766
[TBL] [Abstract][Full Text] [Related]
40. Head-to-Head Comparison of [
Wegen S; van Heek L; Linde P; Claus K; Akuamoa-Boateng D; Baues C; Sharma SJ; Schomäcker K; Fischer T; Roth KS; Klußmann JP; Marnitz S; Drzezga A; Kobe C
Mol Imaging Biol; 2022 Dec; 24(6):986-994. PubMed ID: 35771317
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
